Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Animal Antibiotics and Antimicrobials Market

Animal Antibiotics and Antimicrobials Market - By Product Type (Tetracyclines, Penicillin, Sulfonamides, Macrolides, Aminoglycosides, Lincosamides, Fluoroquinolones, Cephalosporins), By mode of delivery, Animal Type & Global Forecast 2023-2032

  • Report ID: GMI5608
  • Published Date: May 2023
  • Report Format: PDF

Animal Antibiotics and Antimicrobials Market Size

Animal Antibiotics And Antimicrobials Market size was valued at more than USD 4.6 billion in 2022 and is estimated to witness 4% CAGR from 2023-2032. Increased adoption of antibiotics and antimicrobials in animals worldwide coupled with increasing demand for animal derived food products and growing incidences of diseases in animals led the market growth.
 

Animal Antibiotics And Antimicrobials Market

To get key market trends   Download Free Sample

The animal-derived food products such as milk, eggs, meat, and other act a major source of nutrition and plays a prominent role in the human diet. The companies involved in the production of animal-derived food are focusing on developing healthy herd or disease-free herd through utilization of animal antibiotics and antimicrobials on precautionary basis.
 

The Packaged Facts report on Global Meat & Poultry trends, the global meat and poultry consumption is expected to reach 313 million metric tons in 2023, at a year-on-year growth rate of 1.4%.
 

The rising demand for zoonotic diseases, such as SARS-CoV-2-induced Covid-19, has played a role in the global expansion of the animal antibiotics and antimicrobials market. There has been a rise in the demand for animal-derived food products, and the execution of rules on the prevention of disease transmission among animals in recent years.
 

Animal Antibiotics and Antimicrobials Market Trends

There has been rising concerns regarding the health of animals. The rising animal healthcare spending and the growing demand for pet insurance will lead to high demand for animal pharmaceuticals including antibiotics and antimicrobials, which is the most significant factor driving the revenue for this market. Increasing initiatives concerning animal health and welfare along with increasing incidence of zoonotic diseases are also expected to accelerate the overall progression of the market.
 

Furthermore, the surging demand for dairy products, and subsequent rise in livestock population facilitated by organized farming which will further expand the animal antibiotics antimicrobials market's growth rate in the future.
 

Animal Antibiotics and Antimicrobials Market Analysis

Animal Antibiotics and Antimicrobials Market, By Type, 2021 - 2032 (USD Bn)

Learn more about the key segments shaping this market   Download Free Sample

The animal antibiotics and antimicrobials market by product type is segmented into tetracyclines, penicillin, sulphonamides, macrolides, aminoglycosides, lincosamides, fluoroquinolones, cephalosporins, and other antibiotics & antimicrobials. The tetracyclines segment accounted for over 42.6% share of the animal antibiotics and antimicrobials in 2022.
 

Tetracyclines exhibit advantages such as the highest potency against pathogenic microorganisms, are well-absorbed, show low toxicity, and are relatively inexpensive compared to other animal antimicrobial and antibiotic products. These advantages contribute to the large share of this product segment.
 

Global Animal Antibiotics and Antimicrobials Market, By Animal Type, 2022

Learn more about the key segments shaping this market   Download Free Sample

The animal antibiotics and antimicrobials market is classified into livestock and companion animals. In 2022, the livestock animals segment held largest share of 57.9% in the market. The rising demand for animal-derived food products and the implementation of regulations to prevent the spread of animal diseases are also projected to cushion the growth of the market.
 

The market is segmented into Premixes, Oral Powders, Oral Solutions, Injections. The Premixes segment is estimated to witness the highest market share for the forecast period. The factor that can be attributed to the growth of the segment is associated with the ease with which it can be given to the animals.

 

North America Animal Antibiotics & Antimicrobials Market, 2020 - 2032 ($ Bn)

Looking for region specific data?   Download Free Sample

Asia Pacific animal antibiotics and antimicrobials market region is expected to showcase highest growth rate during the forecast period. The high growth rate of Asia Pacific region can be attributed to the rise in the region’s animal population, increasing demand for animal-derived food products, growth in pet insurance, and growing animal health expenditure compared to other regions.
 

Animal Antibiotics and Antimicrobials Market Share

The animal antibiotics and antimicrobials market consists of several players including:

  • Zoetis Inc.
  • Merck & Co., Inc.
  • Elanco Animal Health Incorporated
  • Boehringer Ingelheim International GmbH
  • Ceva Sante Animal
  • Virbac
  • Vetoquinol
  • Bayer AG
  • Novartis AG
  • Eli Lilly
  • Sanofi
  • Arthrex 

to maintain a competitive edge in the industry.
 

 Some of the recent industry developments:

  • In August 2020, Elanco, a US-based pharmaceutical company that manufacturers medicines and vaccinations for pets and livestock, acquired Bayer’s animal health business unit for $6.89 billion. With this acquisition, Elanco strengthened its product portfolio by adding Bayer’s products. In addition to this, Elanco improved its research and development pipeline and broaden its range of animal health products.
     

The animal antibiotics and antimicrobials market research report include an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report


By Product Type,

  • Tetracyclines
  • Penicillin
  • Sulfonamides
  • Macrolides
  • Aminoglycosides
  • Lincosamides
  • Fluoroquinolones
  • Cephalosporins
  • Other antibiotics and antimicrobials

By Mode of Delivery,

  • Premixes
  • Oral Solutions
  • Oral Powders
  • Injections

By Animal Type,

  • Companion Animal
    • Dogs
    • Cats
    • Horses
    • Other Companion Animals
  • Livestock Animal 
    • Cattle
    • Swine
    • Poultry
    • Sheep & Goats

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia and New Zealand
    • South Korea
    • Rest of Asia pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Turkey
    • Rest of Middle East & Africa

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for animal antibiotics & antimicrobials was valued at over USD 4.6 billion in 2022 and is forecasted to reach over USD 6.7 billion by 2032.
The tetracyclines segment accounted for over 42.6% share of the animal antibiotics and antimicrobials market in 2022 and is expected to record robust demand due to its highest potency against pathogenic microorganisms.
The livestock animals segment held a 57.9% market share in 2022 and is projected to expand further driven by rising demand for animal-based products & the introduction of regulations to prevent diseases.
Zoetis Inc., Merck & Co., Inc., Boehringer Ingelheim International GmbH, Virbac, Vetoquinol, Bayer AG, Novartis AG, Eli Lilly, and Sanofi are some of the leading players in the animal antibiotics and antimicrobials market.

Animal Antibiotics and Antimicrobials Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 12
  • Tables & Figures: 357
  • Countries covered: 18
  • Pages: 200
 Download Free Sample
 Download Free Sample